Antigenic relationships between Mycobacterium vaccae, M. nonchromogenicum, and M. leprae were examined in mice and guinea pigs injected with M. vaccae or M. nonchromogenicum suspensions. The growth of both organisms in outbred ICR and four inbred mouse strains was followed up to 30 days. M. nonchromogenicum persisted in the livers and spleens of the inbred mice substantially better than did the M. vaccae population in the same mouse strains. A translucent colony variant of M. vaccae isolated from the opossum survived in vivo better than the opaque colony isolated from opossums and cattle. Persistence of M. vaccae and M. nonchromogenicum was not markedly increased in T-celldepleted (nude) mice. Normal mice infected with increasing numbers of M. vaccae did not develop delayed-type hypersensitivity to the homologous M. vaccae cytoplasmic protein antigen. When heat-killed M. vaccae were incorporated into Freund adjuvant, both mice and guinea pigs developed delayed hypersensitivity to cytoplasmic antigens prepared from M. vaccae, M. nonchromogenicum, and M. keprae, but not to purified protein derivative. Both M. nonchromogenicum and M. vaccae vaccines cross-sensitized guinea pigs to the M. leprae cytoplasmic antigens.
The development of an effective vaccine for use against human leprosy poses a number of unique practical problems which, so far, have defied solution (19) . Live BCG increased resistance to naturally acquired leprosy in some, but not in other field trials (2, 5) . BCG is known to possess antigens which result in humoral, rather than cellular, cross-reactions with M. leprae (22, 23) . Somewhat surprisingly, M. vaccae and M. nonchromogenicum were found to possess crossreactive antigens which behave in a manner similar to that of M. leprae antigens in lepromatous leprosy patients (31) . This antigenic relationship was confirmed by lymphocyte transformation (26) and leukocyte migration inhibition tests (25) . The characteristic type of lepromin anergy seen in lepromatous leprosy patients occurred with M. vaccae and M. nonchromogenicum suspensions, but did not occur with antigens prepared from BCG or other slow-growing mycobacteria (27) . Stanford (30) proposed that M. vaccae or M. nonchromogenicum might therefore function as suitable vaccine strains for use against human leprosy.
The possibility of developing an avirulent cross-reactive vaccine against this important human disease is an attractive one (18, 19) . However, preliminary studies indicate that even massive doses of M. vaccae or M. nonchromogenicum are quickly eliminated from the tissues (14) . The (28) . The colony variants remained stable when serially cultured on solid media. The separated colony types were grown in gently stirred 7H9 broth at 370C for 7 days, and the suspensions were stored at -70'C until required (14) . The viability of each suspension was checked after thawing and dilution in 0.05% Tween-saline by plating on 7H10 agar incubated at 370C in sealed plastic bags for 2 to 3 weeks.
Animal inoculation. A frozen ampoule was thawed at 370C, homogenized mechanically in an equal volume of fresh medium (to break up the clumps), and diluted appropriately in Tween-saline, and 0.2 ml was injected intravenously (14) . Guinea pigs were injected subcutaneously into recently shaven mid-flank skin with 0.1 ml of suspension (9) . Immediately after inoculation, the viability of each suspension was determined on 7H10 agar plates (10) . Bacterial enumeration of in vivo populations. Groups of five randomly selected mice were sacrificed at weekly intervals, and the inoculation site, the draining lymph node, lungs, liver, and spleen were removed aseptically and homogenized separately in sterile Tween-saline (9, 13) . Viable counts were made on 7H10 agar plates incubated at 370C for 2 to 3 weeks.
The counting error for the five replicate determinations varied from 10 to 20%, as reported in earlier studies (10) .
Delayed hypersensitivity tests. Mice were footpad tested with 5 jig of cytoplasmic protein antigen (CPA) isolated from sonically disrupted mycobacteria (16, 27) in 0.02 ml of 0.05% Tween-saline or with 108 heat-killed whole mycobacterial cells (18) . M. leprae were prepared from human wedge biopsies obtained by the Leonard Wood Memorial Laboratory, Philippines. The biopsy was trimmed of fatty tissue after autoclaving and homogenized in 0.3 M buffered sucrose by using an Omnimix blender. The cells were centrifuged at 300 x g for 5 min to remove tissue pieces, and the supernatant fluid was centrifuged at 15,000 x g for 20 min at 4°C. The pellet was resuspended in 1% Triton X-100 in 0.3 M buffered sucrose and washed twice with buffered sucrose before being treated overnight with 100 ,Ig of collagenase per ml (Worthington Biochemicals, Freehold, N.J.) in the presence of 10-4 M calcium chloride and 0.05% sodium azide. The bacilli were centrifuged at 15,000 x g for 20 min and resuspended in 0.05% Tween-saline. The suspension was counted microscopically (29) and standardized to 5 x 108 bacilli per ml. A small amount of CPA was prepared from the human M. leprae suspension by sonic disruption followed by ultracentrifugation at 100,000 x g for 90 min. The protein content of the various CPA preparations was checked by the method of Lowry et al. (24) and standardized to 300
Ag of protein per ml. The amount of foot swelling to 5 or 10 jg of CPA was measured after 3, 6, 24, 48, and 72 h by using dial gauge calipers (10) . The swelling responses to 5 x 107 whole cells were read at twiceweekly intervals for up to 6 weeks. Guinea pigs were skin tested with 5 to 10 ,.g of purified protein derivative (PPD) or CPA in 0.1 ml of buffered saline injected into clipped flank skin (9) . The diameters of skin erythema and skin fold thickness were measured after 3, 24, and 48 h as described earlier (15) . An increase of 0.2 mm or more in foot thickness or 1 mm in skin fold thickness (after subtraction of the dilution controls) was significant at the 1% level.
RESULTS
Growth of M. vaccae in inbred mice. Extensive differences have been reported to exist between the susceptibility of different mouse strains to mycobacterial challenge (6, 20) . Previous studies indicated that M. vaccae was unable to persist when introduced into normal ICR mice by the intravenous or subcutaneous routes (14) . The present study examined the growth of the type strain of M. vaccae (TMC 1526) when injected intravenously into eight different strains of mice. The data shown in Fig. 1 indicate that this organism was unable to establish a persisting infection in any of the inbred mouse strains tested, although some quantitative differences were observed in the actual rate of decline. M. vaccae failed to persist in the lungs of any of the mice, but their disappearance may have been due to the small initial size of this population within the lungs, rather than to an enhanced local rate of inactivation. The rate of decline by the liver and spleen populations was approximately equal in all of the mice for the first 7 days, but then slowed so that a few viable bacilli were recovered from the BDA-2, C3H, and BALB/c mice even after 60 days.
Similar growth studies were carried out with the translucent and the opaque-domed colony variant of the opossum strain of M. vaccae, as well as a bovine isolate which could only be obtained in the mucoid and the opaque colony forms. Both the mucoid and opaque bovine colony types behaved identically in the various mouse strains to the opossum opaque type and were not included for that reason. The translucent opossum variant of M. vaccae survived better than the type strain TMC 1526 after intravenous inoculation into the inbred mice (Fig. 2) . In fact, the residual population in the C57BL mice after 4 30 (Fig. 3) .
Growth of M. nonchronwgenicum in inbred mice. Mice infected with 107 viable M.
nonchromogenicum TMC 1481 (translucent colony type) showed a slower decline in viability over the first 4 weeks of the infection. The BALB/c and DBA-2 mouse counts tended to stabilize so that many of the animals contained substantial numbers of mycobacteria even after 3 months (Fig. 4) Delayed hypersensitivity to CPA. The ability of M. nonchromogenicum and M. vaccae to survive in vivo for several weeks raises the possibility that the infected mice may develop delayed-type hypersensitivity responses to antigens isolated from these organisms. Mice were infected with increasing numbers of viable M. vaccae (106 to 108), and footpads were tested at weekly intervals with 10 ,ug of the homologous CPA. Although substantial 3-h swelling reactions developed, none of the mice exhibited significant 24-h swelling responses even after 3 weekly doses of 5 x 106 viable M. vaccae (Table   1 ). However, if the M. vaccae was emulsified in Freund adjuvant, significant 24-h reactions were observed which were consistently greater than the 3-h swelling responses.
When live M. vaccae were injected into strain 2 guinea pigs, no skin reactivity developed unless the organisms were suspended in Freund adjuvant. Injection of M. vaccae, M. nonchromogenicum, and M. leprae CPA into guinea pig skin after sensitization with heat-killed M. tuberculosis or M. vaccae resulted in significant delayed-type hypersensitivity responses ( Table 2 ). The M. leprae CPA also resulted in a significant delayed-type hypersensitivity reaction in M. vaccae-immunized guinea pigs, with no crossreaction to PPD. bLiV., Intravenously;sxc., subcutaneously. H-K, Heat killed. 3.0 ± 0.5 12.4 ± 0.7 11.5 ± 0.8 10.6 ± 2.6 16.0 ± 2.6 7.8 ± 0.6 6 h 4.4 ± 0.5 13.8 ± 0.8 13.4 ± 0.6 14.0 ± 0.6 14.0 ± 0.6 12.0 ± 1.0 1 2.8 ± 0.5 10.0 ± 0.5 9.9 ± 0.8 7.6 ± 0.6 7.6 ± 0.6 10.2 ± 1.5 2 2.2 ± 0.6 3.2 ± 0.7 4.9 ± 0. A similar swelling response was observed in M. vaccae-infected guinea pigs skin tested with 108 heat-killed M. vaccae 2 weeks later. There was an early peak (3 to 24 h) followed by a decline to nonsignificant levels and a second peak about day 21 (Fig. 6) . A decreasing response was also seen as the vaccinating dose was increased from 106 to 108 viable units. DISCUSSION Previous studies of the growth of M. vaccae in intravenously infected ICR mice (14) showed that this organism was unable to survive in vivo for more than 1 week, even when introduced into the tissues in large numbers. Examination of the various growth curves shown in Fig. 1 indicates that the outbred ICR mouse had been an unfortunate choice for the earlier studies (14) , since persistence was noticeably better in several of the inbred mouse strains infected with the various M. vaccae substrains tested during the present investigation. The differences in survival shown by the inbred mice were relatively small, but there was no question that the colonial form shown by the challenge strain was a highly important factor in determining the relative survival of the in-culum in vivo. The opossum strain of M. vaccae persisted in vivo much better than the type strain (TMC 1526) or the bovine isolate. The translucent to opaque colony variation seems to be essentially the same as that described for M. avium and M. intracellulare (17, 28) . In the latter group, this colonial variation was associated with changes in virulence, both in chickens and mice (1). Although it is not possible to refer to M. vaccae or M. nonchromogenicum in terms of mouse virulence, the translucent colony variants did persist in vivo far longer than the opaque colony type (cf. Fig. 2  and 3 ). Thus, any attempt to develop a living M. vaccae vaccine would have to employ the translucent variant, and further study of this strain in C57BL, DBA-2, or the B6D2 F. hybrid mice would seem to be worthwhile.
M. nonchromogenicum persisted in the inbred mice far better than did M. vaccae. However, none of the heavily infected mice developed obvious signs of disease, even after many months. When M. nonchromogenicum was introduced into the athymic mice, there was no sign of a progressive infection and none of the animals died as a result of the infection. This was taken as evidence that M. vaccae and M. nonchromogenicum are fully avirulent, even for immunosuppressed mice. However, the question of their potential virulence as human vaccines is still unanswered. Stanford (30) cites a single case of M. nonchromogenicum infection in humans. The usual source of this organism is soil and water, and most workers consider it to be completely innocuous for humans (32) . On the other hand, M. vaccae is frequently isolated from bovine lymph nodes and from milk (4), but whether this organism can cause infections in humans has not yet been established. It is not clear whether the opossum isolates were primarily responsible for the lymph node infections seen in these animals or whether they were present merely as secondary invaders or adventitious contaminants (P. O'Hara, personal communication).
Anti-tuberculous immunity is a T-cell-mediated response developing as a result of the introduction of living Mycobacteria into the tissues (7, 8 (3, 10) . However, not all living attenuated mycobacteria are capable of inducing significant levels of cell-mediated immunity (10, 13) . This inability on the part of the nonpersisting mycobacterial inoculum to sensitize the host occurs despite the presence of the relevant antigens in the bacterial cell (12) . Active sensitization requires a persistent, metabolically active population of bacteria in the spleen or the draining lymph node (13) . Thus the injection of living M. vaccae (or M. nonchromogenicum) may still fail to induce detectable levels of cellular hypersensitivity, if they are unable to persist within the vaccinated host (Table 1) . In this regard, the development of delayed-type hypersensitivity to the CPA preparation is merely a convenient parameter of the cellular immune response to the living M. vaccae or M. nonchromogenicum. The inability of live M. vaccae to induce delayed hypersensitivity responses to the M. vaccae CPA, unless the organisms are incorporated into Freund adjuvant, makes it unlikely that this organism will prove to be a practical anti-leprosy vaccine for use in humans. However, until its growth behavior has been established in human volunteers, it is difficult to make a final assessment on this point. Some skin reactivity to M. vaccae CPA and M. leprae CPA was seen in guinea pigs immunized with heat-killed M. vaccae (Table 2 ). These same animals displayed no cross-reactivity when the skin test antigens were tested in BCG-vaccinated controls. Interestingly, the guinea pigs receiving live M. vaccae developed substantial late skin responsiveness to the M. vaccae whole-cell antigen (Fig. 6) . A similar response was observed in actively infected mice footpad tested with the same wholecell preparation (Table 3 ). This same cross-reactivity developed in the M. vaccae-infected mice and guinea pigs tested with the M. leprae antigens. Such reactivity was quite significant and seems to justify further study of these attenuated mycobacteria as potential anti-leprosy vaccines for use in humans.
